Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Savi

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|March 1, 1981
Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicinF Giuliani, A M Casazza, A Di Marco, et al.
Tumori|April 30, 1983
Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicityF Zunino, O Tofanetti, A Besati, et al.
Tumori|December 31, 1982
Reduction of lethal toxicity of doxorubicin by amrinoneR Bossa, I Galatulas, G Savi, et al.
European Journal of Cancer|May 1, 1979
Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in miceF Giuliani, A Di Marco, A M Casazza, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and ratsF Villani, C Manzotti, M Mella, et al.
Lasers in Surgery and Medicine|January 1, 1986
A study on the possible involvement of nonlinear mechanism of light absorption by HpD with Nd:YAG laserR Marchesini, E Melloni, G Pezzoni, et al.
Tumori|August 31, 1983
Effectiveness of laser photoradiation therapy following hematoporphyrin derivative administration in the experimental MS-2 tumor modelF Zunino, R Marchesini, E Melloni, et al.
European Journal of Cancer|May 1, 1978
Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcomaF Giuliani, O Bellini, A M Casazza, et al.
British Journal of Cancer|December 1, 1985
Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drugG Pratesi, G Savi, G Pezzoni, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriersF Zunino, G Savi, F Giuliani, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|March 1, 1981
Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicinF Giuliani, A M Casazza, A Di Marco, et al.
Tumori|April 30, 1983
Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicityF Zunino, O Tofanetti, A Besati, et al.
Tumori|December 31, 1982
Reduction of lethal toxicity of doxorubicin by amrinoneR Bossa, I Galatulas, G Savi, et al.
European Journal of Cancer|May 1, 1979
Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in miceF Giuliani, A Di Marco, A M Casazza, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and ratsF Villani, C Manzotti, M Mella, et al.
Lasers in Surgery and Medicine|January 1, 1986
A study on the possible involvement of nonlinear mechanism of light absorption by HpD with Nd:YAG laserR Marchesini, E Melloni, G Pezzoni, et al.
Tumori|August 31, 1983
Effectiveness of laser photoradiation therapy following hematoporphyrin derivative administration in the experimental MS-2 tumor modelF Zunino, R Marchesini, E Melloni, et al.
European Journal of Cancer|May 1, 1978
Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcomaF Giuliani, O Bellini, A M Casazza, et al.
British Journal of Cancer|December 1, 1985
Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drugG Pratesi, G Savi, G Pezzoni, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriersF Zunino, G Savi, F Giuliani, et al.
Pageof 3